Global Chronic Idiopathic Constipation (CIC) Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 149709
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of difficult, infrequent, or incomplete bowel movements.

Scope of the Report:

The worldwide market for Chronic Idiopathic Constipation (CIC) Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Chronic Idiopathic Constipation (CIC) Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Actavis

Chugai Pharmaceutical

Ferring International Center

Synergy Pharmaceuticals

Pfizer

GlaxoSmithKline

Roche Holding

Sanofi

Bayer

Salix Pharmaceuticals

Sucampo Pharmaceuticals

Ironwood Pharmaceuticals

Progenics Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Lubiprostone

Linaclotide

Others

Market Segment by Applications, can be divided into

Hospitals & Clinics

Ambulatory Surgical Centres

Long Term Care Centres

Others

There are 15 Chapters to deeply display the global Chronic Idiopathic Constipation (CIC) Drugs market.

Chapter 1, to describe Chronic Idiopathic Constipation (CIC) Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, with sales, revenue, and price of Chronic Idiopathic Constipation (CIC) Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Chronic Idiopathic Constipation (CIC) Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Chronic Idiopathic Constipation (CIC) Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Chronic Idiopathic Constipation (CIC) Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Chronic Idiopathic Constipation (CIC) Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Lubiprostone

1.2.2 Linaclotide

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals & Clinics

1.3.2 Ambulatory Surgical Centres

1.3.3 Long Term Care Centres

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Actavis

2.1.1 Business Overview

2.1.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Chugai Pharmaceutical

2.2.1 Business Overview

2.2.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Ferring International Center

2.3.1 Business Overview

2.3.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Synergy Pharmaceuticals

2.4.1 Business Overview

2.4.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 GlaxoSmithKline

2.6.1 Business Overview

2.6.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Roche Holding

2.7.1 Business Overview

2.7.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Sanofi

2.8.1 Business Overview

2.8.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Bayer

2.9.1 Business Overview

2.9.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Salix Pharmaceuticals

2.10.1 Business Overview

2.10.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Sucampo Pharmaceuticals

2.11.1 Business Overview

2.11.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Ironwood Pharmaceuticals

2.12.1 Business Overview

2.12.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Progenics Pharmaceuticals

2.13.1 Business Overview

2.13.2 Chronic Idiopathic Constipation (CIC) Drugs Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Chronic Idiopathic Constipation (CIC) Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Chronic Idiopathic Constipation (CIC) Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Chronic Idiopathic Constipation (CIC) Drugs Market Analysis by Regions

4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

4.5 South America Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

5 North America Chronic Idiopathic Constipation (CIC) Drugs by Countries

5.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

6 Europe Chronic Idiopathic Constipation (CIC) Drugs by Countries

6.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

6.3 UK Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

6.4 France Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs by Countries

7.1 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

7.5 India Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

8 South America Chronic Idiopathic Constipation (CIC) Drugs by Countries

8.1 South America Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs by Countries

9.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2013-2018)

10 Global Chronic Idiopathic Constipation (CIC) Drugs Market Segment by Type

10.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Type (2013-2018)

10.2 Lubiprostone Sales Growth and Price

10.2.1 Global Lubiprostone Sales Growth (2013-2018)

10.2.2 Global Lubiprostone Price (2013-2018)

10.3 Linaclotide Sales Growth and Price

10.3.1 Global Linaclotide Sales Growth (2013-2018)

10.3.2 Global Linaclotide Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Chronic Idiopathic Constipation (CIC) Drugs Market Segment by Application

11.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2013-2018)

11.2 Hospitals & Clinics Sales Growth (2013-2018)

11.3 Ambulatory Surgical Centres Sales Growth (2013-2018)

11.4 Long Term Care Centres Sales Growth (2013-2018)

11.5 Others Sales Growth (2013-2018)

12 Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2018-2023)

12.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Chronic Idiopathic Constipation (CIC) Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2018-2023)

12.2.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2018-2023)

12.2.4 South America Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2018-2023)

12.3 Chronic Idiopathic Constipation (CIC) Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share Forecast by Type (2018-2023)

12.4 Chronic Idiopathic Constipation (CIC) Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Chronic Idiopathic Constipation (CIC) Drugs Picture

Table Product Specifications of Chronic Idiopathic Constipation (CIC) Drugs

Figure Global Sales Market Share of C

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery